Trial Profile
A cohort study of anticholinergic drugs in South Asian women with detrusor overactivity.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2019
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 06 Nov 2019 Status changed from recruiting to discontinued.
- 01 Jun 2011 New trial record